Drug Formulations and Space Innovation

This chapter explores the impact of Series C funding on a company pioneering drug formulations in space, highlighting the shift to in-house manufacturing for better supply chain control. It discusses the unique advantages of microgravity in pharmaceuticals, advancements in aerospace technology, and the integration of AI within the pharmaceutical and defense sectors.